HTA Council Recommendation (as of 13 March 2025) The HTA Council positively recommends High Risk Human Papillomavirus (HrHPV) DNA Test for financing of the Department of Health (DOH) and/or PhilHealth. HRHPV DNA test is recommended for cervical cancer screening in women ages 30 – 65 years, every 5 years as long as the test adheres continue reading : High-Risk Human Papilloma Virus (HrHPV) Testing (DNA Test) for early detection of cervical cancer
Visualization in acetic acid (VIA) for screening of cervical cancer
HTA Council Recommendation (as of 13 March 2025) The HTA Council positively recommends Visual Acetic Acid (VIA) for financing of the Department of Health (DOH) and/or PhilHealth. VIA is recommended for cervical cancer screening in women ages 30-65 years every 3 years, in settings wherein HPV DNA testing is still not operational (See below for continue reading : Visualization in acetic acid (VIA) for screening of cervical cancer